nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A5—Dactinomycin—skin cancer	0.281	0.362	CbGbCtD
Norepinephrine—CYP1A2—Imiquimod—skin cancer	0.224	0.288	CbGbCtD
Norepinephrine—CYP1A2—Vemurafenib—skin cancer	0.123	0.158	CbGbCtD
Norepinephrine—CYP1A2—Dacarbazine—skin cancer	0.094	0.121	CbGbCtD
Norepinephrine—CYP1A2—Fluorouracil—skin cancer	0.0551	0.071	CbGbCtD
Norepinephrine—SLC18A1—head—skin cancer	0.00398	0.0626	CbGeAlD
Norepinephrine—ADRB3—connective tissue—skin cancer	0.00379	0.0596	CbGeAlD
Norepinephrine—SLC6A2—nerve—skin cancer	0.00327	0.0515	CbGeAlD
Norepinephrine—DRD2—nerve—skin cancer	0.00298	0.0469	CbGeAlD
Norepinephrine—PAH—head—skin cancer	0.00286	0.045	CbGeAlD
Norepinephrine—SLC18A1—lymph node—skin cancer	0.00279	0.0439	CbGeAlD
Norepinephrine—ADRB3—female reproductive system—skin cancer	0.00267	0.042	CbGeAlD
Norepinephrine—SLC22A3—nipple—skin cancer	0.00217	0.0341	CbGeAlD
Norepinephrine—ADRA1D—epithelium—skin cancer	0.00202	0.0319	CbGeAlD
Norepinephrine—ADRA2C—nipple—skin cancer	0.00165	0.0259	CbGeAlD
Norepinephrine—SLC22A5—nipple—skin cancer	0.00158	0.0248	CbGeAlD
Norepinephrine—ADRB1—connective tissue—skin cancer	0.00155	0.0244	CbGeAlD
Norepinephrine—SLC22A3—connective tissue—skin cancer	0.00154	0.0242	CbGeAlD
Norepinephrine—SLC18A2—female reproductive system—skin cancer	0.00152	0.024	CbGeAlD
Norepinephrine—ADRA1D—female reproductive system—skin cancer	0.0015	0.0237	CbGeAlD
Norepinephrine—CYP1A2—nipple—skin cancer	0.00143	0.0225	CbGeAlD
Norepinephrine—ADRA2A—nipple—skin cancer	0.00131	0.0207	CbGeAlD
Norepinephrine—ADRA1B—head—skin cancer	0.00128	0.0202	CbGeAlD
Norepinephrine—SLC18A2—head—skin cancer	0.00127	0.02	CbGeAlD
Norepinephrine—SLC22A3—mammalian vulva—skin cancer	0.00127	0.0199	CbGeAlD
Norepinephrine—ADRA1D—head—skin cancer	0.00126	0.0198	CbGeAlD
Norepinephrine—ADRA1A—epithelium—skin cancer	0.00116	0.0183	CbGeAlD
Norepinephrine—ADRB1—female reproductive system—skin cancer	0.00109	0.0172	CbGeAlD
Norepinephrine—SLC22A3—female reproductive system—skin cancer	0.00108	0.0171	CbGeAlD
Norepinephrine—SLC22A5—skin of body—skin cancer	0.00101	0.0159	CbGeAlD
Norepinephrine—ADRA2C—mammalian vulva—skin cancer	0.000961	0.0151	CbGeAlD
Norepinephrine—SLC22A1—head—skin cancer	0.000948	0.0149	CbGeAlD
Norepinephrine—ADRA2A—connective tissue—skin cancer	0.000931	0.0147	CbGeAlD
Norepinephrine—SLC6A2—female reproductive system—skin cancer	0.000929	0.0146	CbGeAlD
Norepinephrine—ADRB1—head—skin cancer	0.000913	0.0144	CbGeAlD
Norepinephrine—SLC22A3—head—skin cancer	0.000906	0.0143	CbGeAlD
Norepinephrine—ADRA1A—lymphoid tissue—skin cancer	0.000895	0.0141	CbGeAlD
Norepinephrine—SLC18A2—lymph node—skin cancer	0.000891	0.014	CbGeAlD
Norepinephrine—SLC22A5—female reproductive system—skin cancer	0.000788	0.0124	CbGeAlD
Norepinephrine—SLC6A2—head—skin cancer	0.000776	0.0122	CbGeAlD
Norepinephrine—ADRA2A—mammalian vulva—skin cancer	0.000767	0.0121	CbGeAlD
Norepinephrine—ADRA1A—head—skin cancer	0.000722	0.0114	CbGeAlD
Norepinephrine—DRD2—head—skin cancer	0.000707	0.0111	CbGeAlD
Norepinephrine—ADRA2C—head—skin cancer	0.000688	0.0108	CbGeAlD
Norepinephrine—ADRA2A—female reproductive system—skin cancer	0.000657	0.0103	CbGeAlD
Norepinephrine—SLC22A3—lymph node—skin cancer	0.000634	0.00998	CbGeAlD
Norepinephrine—ADRA2A—head—skin cancer	0.000549	0.00863	CbGeAlD
Norepinephrine—SLC6A2—lymph node—skin cancer	0.000543	0.00855	CbGeAlD
Norepinephrine—ADRA2C—lymph node—skin cancer	0.000481	0.00758	CbGeAlD
Norepinephrine—SLC22A5—lymph node—skin cancer	0.000461	0.00726	CbGeAlD
Norepinephrine—ADRA2A—lymph node—skin cancer	0.000384	0.00604	CbGeAlD
Norepinephrine—ADRB2—Signaling Pathways—GLI1—skin cancer	8.75e-05	0.000546	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PTCH1—skin cancer	8.72e-05	0.000544	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—SMO—skin cancer	8.72e-05	0.000544	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GLI2—skin cancer	8.67e-05	0.000541	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CSPG4—skin cancer	8.56e-05	0.000534	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PTGER4—skin cancer	8.49e-05	0.000529	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SUFU—skin cancer	8.48e-05	0.000529	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SUFU—skin cancer	8.4e-05	0.000524	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MC1R—skin cancer	8.4e-05	0.000524	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PTCH1—skin cancer	8.4e-05	0.000524	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—SMO—skin cancer	8.4e-05	0.000524	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PTGER4—skin cancer	8.37e-05	0.000522	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SUFU—skin cancer	8.3e-05	0.000518	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	8.3e-05	0.000518	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—GLI1—skin cancer	8.28e-05	0.000517	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MC1R—skin cancer	8.27e-05	0.000516	CbGpPWpGaD
Norepinephrine—PAH—Disease—NRAS—skin cancer	8.24e-05	0.000514	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	8.23e-05	0.000514	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—SHH—skin cancer	8.23e-05	0.000513	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PTGER4—skin cancer	8.18e-05	0.00051	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GLI1—skin cancer	8.15e-05	0.000508	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	8.04e-05	0.000501	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GLI2—skin cancer	7.99e-05	0.000498	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.88e-05	0.000492	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SUFU—skin cancer	7.85e-05	0.00049	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—SMO—skin cancer	7.8e-05	0.000487	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PTCH1—skin cancer	7.8e-05	0.000487	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SUFU—skin cancer	7.73e-05	0.000482	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GLI2—skin cancer	7.7e-05	0.00048	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MC1R—skin cancer	7.62e-05	0.000476	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PTGER4—skin cancer	7.6e-05	0.000474	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	7.56e-05	0.000472	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GLI1—skin cancer	7.51e-05	0.000469	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ENO2—skin cancer	7.36e-05	0.000459	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MC1R—skin cancer	7.34e-05	0.000458	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GLI1—skin cancer	7.24e-05	0.000452	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ENO2—skin cancer	7.16e-05	0.000447	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GLI2—skin cancer	7.15e-05	0.000446	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	7.14e-05	0.000445	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SUFU—skin cancer	7.12e-05	0.000444	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SHH—skin cancer	7.1e-05	0.000443	CbGpPWpGaD
Norepinephrine—PAH—Disease—KRAS—skin cancer	7.1e-05	0.000443	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RASA1—skin cancer	7.05e-05	0.00044	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	7.05e-05	0.00044	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—TP53—skin cancer	6.95e-05	0.000434	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SUFU—skin cancer	6.86e-05	0.000428	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ENO2—skin cancer	6.86e-05	0.000428	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	6.83e-05	0.000426	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MC1R—skin cancer	6.82e-05	0.000426	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—ERCC2—skin cancer	6.82e-05	0.000425	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SMO—skin cancer	6.73e-05	0.00042	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PTCH1—skin cancer	6.73e-05	0.00042	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GLI1—skin cancer	6.73e-05	0.00042	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PTGER4—skin cancer	6.55e-05	0.000409	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	6.54e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SHH—skin cancer	6.47e-05	0.000403	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RASA1—skin cancer	6.43e-05	0.000401	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SHH—skin cancer	6.41e-05	0.0004	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SUFU—skin cancer	6.38e-05	0.000398	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RASA1—skin cancer	6.37e-05	0.000397	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—IL6—skin cancer	6.36e-05	0.000397	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SHH—skin cancer	6.33e-05	0.000395	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RASA1—skin cancer	6.29e-05	0.000392	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SMO—skin cancer	6.13e-05	0.000382	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTCH1—skin cancer	6.13e-05	0.000382	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SMO—skin cancer	6.08e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTCH1—skin cancer	6.08e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	6.07e-05	0.000379	CbGpPWpGaD
Norepinephrine—PAH—Disease—HRAS—skin cancer	6.03e-05	0.000376	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTCH1—skin cancer	6e-05	0.000374	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SMO—skin cancer	6e-05	0.000374	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SHH—skin cancer	5.99e-05	0.000373	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTGER4—skin cancer	5.97e-05	0.000372	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RASA1—skin cancer	5.95e-05	0.000371	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TERT—skin cancer	5.93e-05	0.00037	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTGER4—skin cancer	5.91e-05	0.000369	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SHH—skin cancer	5.89e-05	0.000368	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PLIN2—skin cancer	5.86e-05	0.000365	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RASA1—skin cancer	5.86e-05	0.000365	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTGER4—skin cancer	5.84e-05	0.000364	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ENO2—skin cancer	5.82e-05	0.000363	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	5.81e-05	0.000362	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—HRAS—skin cancer	5.8e-05	0.000361	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—FOXO4—skin cancer	5.79e-05	0.000361	CbGpPWpGaD
Norepinephrine—PAH—Disease—IL6—skin cancer	5.77e-05	0.00036	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SMO—skin cancer	5.68e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTCH1—skin cancer	5.68e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SMO—skin cancer	5.59e-05	0.000348	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTCH1—skin cancer	5.59e-05	0.000348	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTGER4—skin cancer	5.53e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTGER4—skin cancer	5.44e-05	0.000339	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SHH—skin cancer	5.43e-05	0.000339	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—HRAS—skin cancer	5.4e-05	0.000337	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RASA1—skin cancer	5.4e-05	0.000337	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—FOXO4—skin cancer	5.27e-05	0.000329	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SHH—skin cancer	5.23e-05	0.000326	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—FOXO4—skin cancer	5.22e-05	0.000326	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RASA1—skin cancer	5.2e-05	0.000324	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—FOXO4—skin cancer	5.16e-05	0.000322	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SMO—skin cancer	5.15e-05	0.000321	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTCH1—skin cancer	5.15e-05	0.000321	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—NRAS—skin cancer	5.12e-05	0.00032	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTGER4—skin cancer	5.01e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—NRAS—skin cancer	5e-05	0.000312	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SMO—skin cancer	4.96e-05	0.000309	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTCH1—skin cancer	4.96e-05	0.000309	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—FOXO4—skin cancer	4.88e-05	0.000304	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SHH—skin cancer	4.86e-05	0.000303	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RASA1—skin cancer	4.83e-05	0.000301	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	4.83e-05	0.000301	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	4.8e-05	0.0003	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—NRAS—skin cancer	4.79e-05	0.000299	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CSPG4—skin cancer	4.72e-05	0.000295	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—BRAF—skin cancer	4.7e-05	0.000293	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	4.61e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SMO—skin cancer	4.61e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	4.49e-05	0.00028	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—FOXO4—skin cancer	4.43e-05	0.000276	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—KRAS—skin cancer	4.41e-05	0.000275	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—KRAS—skin cancer	4.3e-05	0.000268	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ERCC2—skin cancer	4.28e-05	0.000267	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	4.27e-05	0.000266	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ERCC2—skin cancer	4.16e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—KRAS—skin cancer	4.12e-05	0.000257	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PTGS2—skin cancer	4.09e-05	0.000255	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ERCC2—skin cancer	3.99e-05	0.000249	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	3.96e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—skin cancer	3.92e-05	0.000244	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—NRAS—skin cancer	3.89e-05	0.000242	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TERT—skin cancer	3.87e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—HRAS—skin cancer	3.75e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—skin cancer	3.66e-05	0.000228	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—HRAS—skin cancer	3.66e-05	0.000228	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TERT—skin cancer	3.52e-05	0.00022	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—HRAS—skin cancer	3.5e-05	0.000218	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—skin cancer	3.5e-05	0.000218	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TERT—skin cancer	3.49e-05	0.000218	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TERT—skin cancer	3.45e-05	0.000215	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ERCC2—skin cancer	3.38e-05	0.000211	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—KRAS—skin cancer	3.35e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TERT—skin cancer	3.26e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	3.26e-05	0.000203	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ENO2—skin cancer	3.21e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TERT—skin cancer	3.21e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—BRAF—skin cancer	3.06e-05	0.000191	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—skin cancer	2.97e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—NRAS—skin cancer	2.97e-05	0.000185	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TERT—skin cancer	2.96e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NRAS—skin cancer	2.95e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—NRAS—skin cancer	2.94e-05	0.000183	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—NRAS—skin cancer	2.9e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TERT—skin cancer	2.85e-05	0.000178	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—HRAS—skin cancer	2.84e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	2.8e-05	0.000175	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—BRAF—skin cancer	2.79e-05	0.000174	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—BRAF—skin cancer	2.76e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—NRAS—skin cancer	2.75e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—BRAF—skin cancer	2.73e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	2.7e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TERT—skin cancer	2.65e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—BRAF—skin cancer	2.58e-05	0.000161	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PTGS2—skin cancer	2.56e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—KRAS—skin cancer	2.55e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—KRAS—skin cancer	2.54e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—BRAF—skin cancer	2.54e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—KRAS—skin cancer	2.53e-05	0.000158	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.51e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—KRAS—skin cancer	2.5e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PTGS2—skin cancer	2.49e-05	0.000156	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—NRAS—skin cancer	2.49e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	2.4e-05	0.00015	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PTGS2—skin cancer	2.39e-05	0.000149	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	2.38e-05	0.000149	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—KRAS—skin cancer	2.36e-05	0.000147	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—BRAF—skin cancer	2.34e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	2.33e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—skin cancer	2.28e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—skin cancer	2.26e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—BRAF—skin cancer	2.26e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	2.23e-05	0.000139	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HRAS—skin cancer	2.17e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HRAS—skin cancer	2.16e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HRAS—skin cancer	2.15e-05	0.000134	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—KRAS—skin cancer	2.14e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HRAS—skin cancer	2.12e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—BRAF—skin cancer	2.1e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—skin cancer	2.08e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—skin cancer	2.07e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	2.07e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—skin cancer	2.06e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—skin cancer	2.03e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTGS2—skin cancer	2.03e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—skin cancer	2.01e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	1.98e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—skin cancer	1.92e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—skin cancer	1.92e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	1.92e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—skin cancer	1.89e-05	0.000118	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ERCC2—skin cancer	1.86e-05	0.000116	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.82e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	1.76e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—skin cancer	1.75e-05	0.000109	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—skin cancer	1.74e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—skin cancer	1.74e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—skin cancer	1.71e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—skin cancer	1.68e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—skin cancer	1.66e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	1.63e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—skin cancer	1.62e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—skin cancer	1.6e-05	9.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—skin cancer	1.56e-05	9.74e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—skin cancer	1.51e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—skin cancer	1.49e-05	9.32e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—skin cancer	1.48e-05	9.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—skin cancer	1.47e-05	9.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—skin cancer	1.47e-05	9.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—skin cancer	1.42e-05	8.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—skin cancer	1.41e-05	8.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—skin cancer	1.4e-05	8.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—skin cancer	1.37e-05	8.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—skin cancer	1.35e-05	8.4e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—skin cancer	1.34e-05	8.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—skin cancer	1.33e-05	8.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—skin cancer	1.32e-05	8.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—skin cancer	1.31e-05	8.18e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—skin cancer	1.28e-05	8e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—skin cancer	1.27e-05	7.93e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—skin cancer	1.27e-05	7.9e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—skin cancer	1.25e-05	7.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—skin cancer	1.24e-05	7.74e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—skin cancer	1.23e-05	7.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—skin cancer	1.22e-05	7.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—skin cancer	1.22e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—skin cancer	1.22e-05	7.59e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—skin cancer	1.2e-05	7.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—skin cancer	1.19e-05	7.4e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—skin cancer	1.17e-05	7.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—skin cancer	1.14e-05	7.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—skin cancer	1.13e-05	7.07e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—skin cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—skin cancer	1.12e-05	6.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—skin cancer	1.12e-05	6.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—skin cancer	1.08e-05	6.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—skin cancer	1.08e-05	6.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—skin cancer	1.04e-05	6.47e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—skin cancer	1.03e-05	6.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—skin cancer	1.01e-05	6.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—skin cancer	9.93e-06	6.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—skin cancer	9.64e-06	6.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—skin cancer	9.23e-06	5.76e-05	CbGpPWpGaD
